Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback